In today’s episode of Living Medicine, Dr. Signi Goldman interviews Derek Rinaldo, MA, LCMHC, and LCAS-A, of Clear Life Counseling, about the risks associated with psychedelic-assisted psychotherapy. Together, they explore the potential downfalls of integration, the categories of harm in psychedelic psychotherapy, and the difference between authentic therapeutic outcomes and recreational psychedelic use.
Sandy Newes
Reader Interactions
Continue Reading
-
Sep 24, 2026 The Art of Psychedelic Therapy: Healing Through the Body and Intentional Use of Relationships
Dr. Sandra (Sandy) Newes, PhD, is a licensed psychiatrist and the Co-founder and Programming Director...
Read More -
Sep 17, 2026 Trauma-Informed IFS Strategies for Psychedelic Therapy: A Compilation of Insights
Dr. Sandra (Sandy) Newes, PhD, is a licensed psychiatrist and the Co-founder and Programming Director...
Read More -
Aug 21, 2026 REST: A Relational, Embodied, and Sacred Approach to Psychedelic Therapy
Rohini Kanniganti, MD, MSPH, HMDC, is the Associate Medical Director at Mountain Valley Hospice and...
Read More -
Aug 6, 2026 Internal Family Systems and Psychedelic Therapy: Why They Work Together So Well
Ted Riskin, LCSW, is the Founder and Lead Psychotherapist at GroupKAP, a program offering ketamine-assisted...
Read More
Leave a Reply
You must be logged in to post a comment.